Eiger BioPharmaceuticals, Inc.
|
-71.03 Million USD
|
113.904%
|
Nanobac Pharmaceuticals, Incorporated
|
-5.92 Million USD
|
266.591%
|
SQZ Biotechnologies Company
|
-64.14 Million USD
|
115.399%
|
Evofem Biosciences, Inc.
|
-17.37 Million USD
|
156.862%
|
Santhera Pharmaceuticals Holding AG
|
94.03 Million USD
|
89.497%
|
Mesoblast Limited
|
-62.38 Million USD
|
115.831%
|
Propanc Biopharma, Inc.
|
-1.53 Million USD
|
743.013%
|
Genus plc
|
73.7 Million USD
|
86.598%
|
VioQuest Pharmaceuticals, Inc.
|
-6.61 Million USD
|
249.391%
|
CNBX Pharmaceuticals Inc.
|
-3.54 Million USD
|
378.461%
|
Marizyme, Inc.
|
-34.28 Million USD
|
128.811%
|
ContraFect Corporation
|
-64.99 Million USD
|
115.196%
|
Nymox Pharmaceutical Corporation
|
-8.77 Million USD
|
212.597%
|
PsyBio Therapeutics Corp.
|
-4.52 Million USD
|
318.219%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-1.4 Million USD
|
804.59%
|
Intellipharmaceutics International Inc.
|
-2.64 Million USD
|
473.499%
|
AXIM Biotechnologies, Inc.
|
-2.32 Million USD
|
525.033%
|
MultiCell Technologies, Inc.
|
-518.04 Thousand USD
|
2006.587%
|
Accustem Sciences Inc.
|
-3.74 Million USD
|
363.638%
|
RVL Pharmaceuticals plc
|
-48.22 Million USD
|
120.48%
|
EV Biologics, Inc.
|
-1.26 Million USD
|
879.477%
|
Q BioMed Inc.
|
-617.62 Thousand USD
|
1699.183%
|
Emmaus Life Sciences, Inc.
|
3.57 Million USD
|
-176.512%
|
Neon Bloom, Inc.
|
-632.4 Thousand USD
|
1661.813%
|
Mosaic ImmunoEngineering Inc.
|
-2.28 Million USD
|
532.351%
|
Biomind Labs Inc.
|
-1.03 Million USD
|
1054.716%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
-Infinity%
|
Oncotelic Therapeutics, Inc.
|
-7.16 Million USD
|
237.922%
|
Skye Bioscience, Inc.
|
-13.54 Million USD
|
172.906%
|
Therapeutic Solutions International, Inc.
|
-1.48 Million USD
|
764.039%
|
THC Farmaceuticals, Inc.
|
-25 Thousand USD
|
39608.0%
|
Arch Therapeutics, Inc.
|
-3.88 Million USD
|
354.279%
|
IMV Inc.
|
-35.52 Million USD
|
127.804%
|
Acro Biomedical Co., Ltd.
|
-15.86 Million USD
|
162.238%
|
Curative Biotechnology, Inc.
|
-2.5 Million USD
|
494.77%
|
GB Sciences, Inc.
|
-1.41 Million USD
|
795.62%
|
Alpha Cognition Inc.
|
-9.7 Million USD
|
201.766%
|
HST Global, Inc.
|
-5303.00 USD
|
186353.064%
|
CSL Limited
|
4.78 Billion USD
|
99.794%
|
Halberd Corporation
|
-74.27 Thousand USD
|
13397.163%
|
Enzolytics Inc.
|
-2.12 Million USD
|
565.451%
|
Resverlogix Corp.
|
-11.74 Million USD
|
184.117%
|
Affymax, Inc.
|
-14.29 Million USD
|
169.094%
|
SYBLEU INC
|
-141.57 Thousand USD
|
7076.711%
|
Nuo Therapeutics, Inc.
|
-3.06 Million USD
|
422.46%
|
argenx SE
|
-216.02 Million USD
|
104.572%
|
MetaStat, Inc.
|
- USD
|
-Infinity%
|
Northwest Biotherapeutics, Inc.
|
-55.33 Million USD
|
117.848%
|
Enzon Pharmaceuticals, Inc.
|
1.21 Million USD
|
-711.586%
|
Arno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RespireRx Pharmaceuticals Inc.
|
-1.49 Million USD
|
758.947%
|
GeneThera, Inc.
|
- USD
|
-Infinity%
|
Inhibitor Therapeutics, Inc.
|
378.84 Thousand USD
|
-2507.142%
|
AVAX Technologies, Inc.
|
-6.11 Million USD
|
261.583%
|
Zenith Capital Corp.
|
-8.6 Million USD
|
214.769%
|
Genscript Biotech Corporation
|
-248.71 Million USD
|
103.971%
|
Ember Therapeutics, Inc.
|
-17.42 Thousand USD
|
56795.942%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sigyn Therapeutics, Inc.
|
-2.44 Million USD
|
503.726%
|
WPD Pharmaceuticals Inc.
|
-176.02 Thousand USD
|
5711.155%
|
American Oriental Bioengineering, Inc.
|
-39.63 Million USD
|
124.919%
|
Provectus Biopharmaceuticals, Inc.
|
-2.89 Million USD
|
441.49%
|
Adynxx, Inc.
|
- USD
|
-Infinity%
|
Helix BioMedix, Inc.
|
-1.04 Million USD
|
1043.982%
|
GlobeStar Therapeutics Corporation
|
6724.00 USD
|
-146791.731%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
-Infinity%
|
Capstone Therapeutics Corp.
|
-1.74 Million USD
|
664.4%
|
Cotinga Pharmaceuticals Inc.
|
-1.92 Million USD
|
614.183%
|
BioStem Technologies, Inc.
|
-7.55 Million USD
|
230.758%
|
ONE Bio Corp.
|
13.61 Million USD
|
27.445%
|
Reve Technologies, Inc.
|
-181.08 Thousand USD
|
5554.254%
|
Burzynski Research Institute, Inc.
|
- USD
|
-Infinity%
|
Wesana Health Holdings Inc.
|
-2.05 Million USD
|
580.165%
|
Agentix Corp.
|
-1.37 Million USD
|
820.026%
|
LadRx Corporation
|
412.28 Thousand USD
|
-2295.685%
|
Cell Source, Inc.
|
-4.27 Million USD
|
331.175%
|
ProtoKinetix, Incorporated
|
-367.22 Thousand USD
|
2789.661%
|
Regen BioPharma, Inc.
|
1.46 Million USD
|
-573.758%
|
Regen BioPharma, Inc.
|
-936.94 Thousand USD
|
1154.166%
|
NovAccess Global Inc.
|
-1.03 Million USD
|
1054.487%
|
Endonovo Therapeutics, Inc.
|
8.85 Million USD
|
-11.557%
|
Itoco Inc.
|
-1.86 Million USD
|
628.466%
|
Rasna Therapeutics, Inc.
|
-379.62 Thousand USD
|
2701.812%
|
Pathfinder Cell Therapy, Inc.
|
-1.11 Million USD
|
985.036%
|
Kadimastem Ltd
|
-2.62 Million USD
|
476.355%
|
Oncology Pharma Inc.
|
- USD
|
-Infinity%
|
Institute of Biomedical Research Corp.
|
-239.15 Thousand USD
|
4230.044%
|
CytoDyn Inc.
|
-18.02 Million USD
|
154.784%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
NDT Pharmaceuticals Inc.
|
-79.02 Thousand USD
|
12597.944%
|
Mobile Lads Corp.
|
-2.24 Million USD
|
540.709%
|
NanoSphere Health Sciences Inc.
|
-12.22 Thousand USD
|
80867.029%
|
Qrons Inc.
|
-40.08 Thousand USD
|
24742.599%
|
Alseres Pharmaceuticals, Inc.
|
-485.67 Thousand USD
|
2133.652%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
-Infinity%
|
Nascent Biotech, Inc.
|
527.43 Thousand USD
|
-1772.655%
|
Rebus Holdings, Inc.
|
-951 Thousand USD
|
1138.591%
|
ImmunoCellular Therapeutics, Ltd.
|
-1.06 Million USD
|
1030.029%
|
International Stem Cell Corporation
|
202 Thousand USD
|
-4789.604%
|
Bioxytran, Inc.
|
-3.82 Million USD
|
358.55%
|
GlobeImmune, Inc.
|
- USD
|
-Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
-Infinity%
|
ProText Mobility, Inc.
|
-52.64 Thousand USD
|
18863.298%
|
Cardax, Inc.
|
- USD
|
-Infinity%
|
VG Life Sciences Inc.
|
-2.46 Million USD
|
501.189%
|
Kaleido Biosciences, Inc.
|
- USD
|
-Infinity%
|
Advaxis, Inc.
|
-35.86 Million USD
|
127.536%
|
Adhera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RenovaCare, Inc.
|
- USD
|
-Infinity%
|
Regnum Corp.
|
-45 Thousand USD
|
22048.889%
|
Innovation Pharmaceuticals Inc.
|
-2.73 Million USD
|
460.738%
|
Neutra Corp.
|
-181.24 Thousand USD
|
5549.47%
|
Windtree Therapeutics, Inc.
|
-20.15 Million USD
|
148.995%
|
PureTech Health plc
|
-11.62 Million USD
|
184.949%
|
Coeptis Therapeutics, Inc.
|
-20.15 Million USD
|
148.999%
|
IXICO plc
|
-707 Thousand USD
|
1497.03%
|
IntelGenx Technologies Corp.
|
-7.68 Million USD
|
228.523%
|
Gelesis Holdings, Inc.
|
-48.34 Million USD
|
120.43%
|
CSL Limited
|
4.73 Billion USD
|
99.791%
|
Cellectis S.A.
|
-92.63 Million USD
|
110.662%
|